Y. Kanematsu-Yamaki

Highly potent antiobesity effect of a short-length peptide YY analog in mice.

N. Amano, H. Hirabayashi, S. Takekawa, 2017, Bioorganic & medicinal chemistry.

Identification of ligand-selective peptidic ActRIIB-antagonists using phage display technology

T. Asami, M. Oka, M. Miwa, 2017, Biochemistry and biophysics reports.

Differential effects of selective agonists of neuromedin U1 and U2 receptors in obese and diabetic mice

J. Noguchi, T. Kaisho, S. Takekawa, 2018, British journal of pharmacology.

Effects of peripheral administration of a Neuromedin U receptor 2-selective agonist on food intake and body weight in obese mice

T. Kaisho, S. Takekawa, H. Fujita, 2017, International Journal of Obesity.

Potent Body Weight-Lowering Effect of a Neuromedin U Receptor 2-selective PEGylated Peptide.

H. Hirabayashi, T. Kaisho, S. Takekawa, 2017, Journal of medicinal chemistry.

A potent neuromedin U receptor 2-selective alkylated peptide.

S. Takekawa, T. Asami, H. Fujita, 2017, Bioorganic & medicinal chemistry letters.

Antiobesity and emetic effects of a short-length peptide YY analog and its PEGylated and alkylated derivatives.

H. Hirabayashi, S. Takekawa, T. Asami, 2017, Bioorganic & medicinal chemistry.